Fms, Recombinant, Human, GST-Tag (CD115, c-fms, CSF-1R, M-CSFR)

Cat# F5724-95A-10ug

Size : 10ug

Brand : US Biological

Request more information



F5724-95A Fms, Recombinant, Human, GST-Tag (CD115, c-fms, CSF-1R, M-CSFR)

Clone Type
Polyclonal
Grade
Purified
Accession #
BC047521
Shipping Temp
Dry Ice
Storage Temp
-70°C

Human FMS (GenBank Accession No. BC047521), (aa538-end) with N-terminal GST tag, expressed in a Baculovirus infected Sf9 cell expression system. ||Specific Activity: |300U/ug. ||Unit Definition:|One unit is defined as the amount of enzyme that will phosphorylate 1 pmol of Tyr substrate per minute at pH 7.4 and 30°C. ||Assay Buffer: |50mM HEPES, pH 7.4, 3mM MgCl2, 3mM MnCl2, 1mM DTT, 3uM Na-orthovanadate, 0.1mM ATP, 30ug/ml Poly (Glu:Tyr) 4:1 substrate, and 1ug/ml recombinant FMS. ||Applications: |Useful for the study of enzyme kinetics, screening inhibitors, and selectivity profiling.||Recommended Dilution:|Optimal dilutions to be determined by the researcher.||Storage and Stability:|Aliquot to avoid repeated freezing and thawing and store at -70°C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Aliquots are stable for at least 6 months.

Applications
Source: Recombinant, Baculovirus infected Sf9 cells|Purity: ≥ 50% by SDS-PAGE|Concentration: As reported|Form: Supplied as a liquid in 25mM Tris-HCl, pH 8.0, 100mM NaCl, 0.05% Tween 20, 10mM glutathione, 3mM DTT, 50% glycerol.||Important Note: This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications without the expressed written authorization of United States Biological.
Form
Supplied as a liquid in 25mM Tris-HCl, pH 8.0, 100mM NaCl, 0.05% Tween 20, 10mM glutathione, 3mM DTT, 50% glycerol.
Purity
≥ 50% by SDS-PAGE
References
1. Walter,M., Lucet,I.S., Patel,O., Broughton,S.E., Bamert,R., Williams,N.K., Fantino,E., Wilks,A.F. and Rossjohn,J. J. Mol. Biol. 367 (3), 839-847 (2007) 2. Li,J., Chen,K., Zhu,L. and Pollard,J.W. Genesis 44 (7), 328-335 (2006)